Health
World-first trial of psilocybin therapy for anxiety disorders to begin in Australia – Happy Mag
First-ever clinical trial investigating the effects of psilocybin assisted psychotherapy to treat generalised anxiety disorder,…
Psilocybin, commonly known as the active ingredient in magic mushrooms, are one of the more popular naturally occurring psychedelics that are consumed for hallucinogenic effects.
Late last week, the Monash University Human Research Ethics Committee (MUHREC)…
Continue Reading
-
Business20 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News16 hours agoWilliam Robinson dies aged 89
-
General16 hours agoCalls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase
-
Business18 hours agoTop brokers name 3 ASX shares to buy today 27 August 2025